Modeling human MLL-AF9 translocated acute myeloid leukemia from single donors reveals RET as a potential therapeutic target
- 26 October 2016
- journal article
- research article
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 31 (5), 1166-1176
- https://doi.org/10.1038/leu.2016.302
Abstract
Leukemia is one of the leading journals in hematology and oncology. It is published monthly and covers all aspects of the research and treatment of leukemia and allied diseases. Studies of normal hemopoiesis are covered because of their comparative relevance.Keywords
This publication has 42 references indexed in Scilit:
- Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid LeukemiaNew England Journal of Medicine, 2013
- An integrated map of genetic variation from 1,092 human genomesNature, 2012
- Expression of RET finger protein predicts chemoresistance in epithelial ovarian cancerCancer Medicine, 2012
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivityNature, 2012
- Acquired copy number alterations in adult acute myeloid leukemia genomesProceedings of the National Academy of Sciences of the United States of America, 2009
- JAK mutations in high-risk childhood acute lymphoblastic leukemiaProceedings of the National Academy of Sciences of the United States of America, 2009
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesNature Protocols, 2008
- Microenvironment Determines Lineage Fate in a Human Model of MLL-AF9 LeukemiaCancer Cell, 2008
- B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcomeProceedings of the National Academy of Sciences of the United States of America, 2007
- Transformation from committed progenitor to leukaemia stem cell initiated by MLL–AF9Nature, 2006